236 related articles for article (PubMed ID: 30574827)
1. Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment.
Grillone A; Battaglini M; Moscato S; Mattii L; de Julián Fernández C; Scarpellini A; Giorgi M; Sinibaldi E; Ciofani G
Nanomedicine (Lond); 2019 Mar; 14(6):727-752. PubMed ID: 30574827
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Magnetic Nanovectors Promote Selective Glioblastoma Cell Death through a Combined Effect of Lysosomal Membrane Permeabilization and Chemotherapy.
Pucci C; De Pasquale D; Marino A; Martinelli C; Lauciello S; Ciofani G
ACS Appl Mater Interfaces; 2020 Jul; 12(26):29037-29055. PubMed ID: 32459082
[TBL] [Abstract][Full Text] [Related]
3. Active Targeting of Sorafenib: Preparation, Characterization, and In Vitro Testing of Drug-Loaded Magnetic Solid Lipid Nanoparticles.
Grillone A; Riva ER; Mondini A; Forte C; Calucci L; Innocenti C; de Julian Fernandez C; Cappello V; Gemmi M; Moscato S; Ronca F; Sacco R; Mattoli V; Ciofani G
Adv Healthc Mater; 2015 Aug; 4(11):1681-90. PubMed ID: 26039933
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S
Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131
[TBL] [Abstract][Full Text] [Related]
5. Preparation and investigation of indirubin-loaded SLN nanoparticles and their anti-cancer effects on human glioblastoma U87MG cells.
Rahiminejad A; Dinarvand R; Johari B; Nodooshan SJ; Rashti A; Rismani E; Mahdaviani P; Saltanatpour Z; Rahiminejad S; Raigani M; Khosravani M
Cell Biol Int; 2019 Jan; 43(1):2-11. PubMed ID: 30080277
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
7. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
[TBL] [Abstract][Full Text] [Related]
8. PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study.
Arduino I; Depalo N; Re F; Dal Magro R; Panniello A; Margiotta N; Fanizza E; Lopalco A; Laquintana V; Cutrignelli A; Lopedota AA; Franco M; Denora N
Int J Pharm; 2020 Jun; 583():119351. PubMed ID: 32339634
[TBL] [Abstract][Full Text] [Related]
9. Tumortropic adipose-derived stem cells carrying smart nanotherapeutics for targeted delivery and dual-modality therapy of orthotopic glioblastoma.
Huang WC; Lu IL; Chiang WH; Lin YW; Tsai YC; Chen HH; Chang CW; Chiang CS; Chiu HC
J Control Release; 2017 May; 254():119-130. PubMed ID: 28336375
[TBL] [Abstract][Full Text] [Related]
10. Stimuli-responsive lipid-based magnetic nanovectors increase apoptosis in glioblastoma cells through synergic intracellular hyperthermia and chemotherapy.
Tapeinos C; Marino A; Battaglini M; Migliorin S; Brescia R; Scarpellini A; De Julián Fernández C; Prato M; Drago F; Ciofani G
Nanoscale; 2018 Dec; 11(1):72-88. PubMed ID: 30357214
[TBL] [Abstract][Full Text] [Related]
11. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles.
Garanti T; Stasik A; Burrow AJ; Alhnan MA; Wan KW
Int J Pharm; 2016 Mar; 500(1-2):305-15. PubMed ID: 26775062
[TBL] [Abstract][Full Text] [Related]
12. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
13. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
[TBL] [Abstract][Full Text] [Related]
14. Modeling of ultra-small lipid nanoparticle surface charge for targeting glioblastoma.
Mendes M; Miranda A; Cova T; Gonçalves L; Almeida AJ; Sousa JJ; do Vale MLC; Marques EF; Pais A; Vitorino C
Eur J Pharm Sci; 2018 May; 117():255-269. PubMed ID: 29486328
[TBL] [Abstract][Full Text] [Related]
15. Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma.
Belletti D; Tosi G; Riva G; Lagreca I; Galliania M; Luppi M; Vandelli MA; Forni F; Ruozi B
Int J Pharm; 2015 Jul; 490(1-2):85-93. PubMed ID: 25987470
[TBL] [Abstract][Full Text] [Related]
16. Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields.
Stewart TS; Nagesetti A; Guduru R; Liang P; Stimphil E; Hadjikhani A; Salgueiro L; Horstmyer J; Cai R; Schally A; Khizroev S
Nanomedicine (Lond); 2018 Feb; 13(4):423-438. PubMed ID: 29345190
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-responsive nutlin-loaded nanoparticles for combined chemotherapy and piezoelectric treatment of glioblastoma cells.
Pucci C; Marino A; Şen Ö; De Pasquale D; Bartolucci M; Iturrioz-Rodríguez N; di Leo N; de Vito G; Debellis D; Petretto A; Ciofani G
Acta Biomater; 2022 Feb; 139():218-236. PubMed ID: 33894347
[TBL] [Abstract][Full Text] [Related]
18. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
19. Targeted nutlin-3a loaded nanoparticles inhibiting p53-MDM2 interaction: novel strategy for breast cancer therapy.
Das M; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2011 Apr; 6(3):489-507. PubMed ID: 21542687
[TBL] [Abstract][Full Text] [Related]
20. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
